February 21, 2024
Impingement Syndrome Market

The Surgical Treatment and Physiotherapy to Drive Growth of the Impingement Syndrome Market

The global Impingement Syndrome Market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Impingement syndrome refers to compression or catching of soft tissues such as tendons between two bony structures. It commonly occurs in the shoulder where rotator cuff tendons get squeezed between the head of the upper arm bone (humerus) and the rim of the shoulder blade (acromion) during arm motions. Common symptoms include shoulder stiffness and pain that gets worse with overhead activities and lifting the arm. Surgical treatment such as acromioplasty and physiotherapy are often recommended to relieve pain and improve movement. Physiotherapy focuses on stretching and strengthening exercises to reduce impingement.

Market key trends:

One of the key trends in the Impingement Syndrome Market Size is the rising adoption of minimally invasive surgical procedures. Traditionally, open surgery involving an incision was the standard treatment option. However, newer arthroscopic techniques performed through small incisions using a miniature camera have gained popularity. They provide benefits such as less postoperative pain, fast recovery, and minimal scarring. Another notable trend is the increasing awareness regarding physiotherapy and non-surgical options for managing shoulder impingement. As conservative treatments can help avoid or delay surgery, many opt for therapeutic exercises and manual therapy techniques first before considering operative interventions. This has driven demand for knowledgeable physiotherapists and equipment to aid rehabilitation.

Porter’s Analysis

Threat of new entrants: The threat of new entrants in the impingement syndrome market is moderate. High capital requirements for research and development pose as a barrier for new companies.
Bargaining power of buyers: The bargaining power of buyers in the impingement syndrome market is moderate. Buyers have a variety of treatment options available.
Bargaining power of suppliers: The bargaining power of suppliers is moderate. The suppliers of devices, equipment and raw materials operate in a fragmented market.
Threat of new substitutes: The threat of new substitutes is low. While alternatives exist, impingement syndrome treatments are well established.
Competitive rivalry: Competition in the impingement syndrome market is high among the key players.

Key Takeaways

The global impingement syndrome market is expected to witness high growth, exhibiting CAGR of 7.5% over the forecast period, due to increasing prevalence of shoulder injuries.

Regional analysis:

North America is expected to dominate the global impingement syndrome market over the forecast period, owing to increase in incidence of shoulder disorders. However, Asia Pacific is anticipated to grow at the fastest pace during the forecast period, immensely contributing to the overall market. This is attributed to rapidly growing geriatric population in countries such as China, India and Indonesia.

Key players:

Key players operating in the impingement syndrome market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., DJO Global, Inc., Össur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., Bioventus LLC. Johnson & Johnson (DePuy Synthes) dominated the global market in 2021 owing to its robust product portfolios in this field.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it